Clonal Evolution of Multiple MyelomaClinical and Diagnostic ...
Plasma cell dyscrasias are a heterogeneous group of diseases characterized by the expansion of bone marrow plasma cells. Malignant transformation of plasma cells depends on the continuity of events resulting in a sequence of well-defined disease stages, from monoclonal gammopathy of undetermined significance (MGUS) through smoldering myeloma (SMM) to symptomatic multiple myeloma (MM ...
Clonal evolution drives tumor progression, dissemination, and relapse in multiple myeloma (MM), with most patients dying of relapsed disease. This multistage process requires tumor cells to enter the circulation, extravasate, and colonize distant bone marrow (BM) sites.
PDF Clonal Evolution in Multiple Myeloma

Introduction Multiple myeloma is a malignant disorder characterized by the uncontrolled proliferation of plasma cells in the bone marrow. Although therapeutic advances have led to significant improvements in survival, the disease remains incurable for the vast majority of patients. One of the most significant biological features contributing to this therapeutic challenge is clonal evolution ...
We investigated genomic and transcriptomic changes in paired tumor samples of 29 in -house multiple myeloma (MM) patients and 28 patients from the MMRF CoMMpass study before and after treatment.

Molecular and immunological mechanisms of clonal evolution ...
Abstract Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal plasma cells in the bone marrow (BM). It is known that early genetic mutations in post-germinal center B/plasma cells are the cause of myelomagenesis.
Clonal evolution drives tumor progression, chemoresistance and relapse in cancer. Little is known about clonal selection induced by therapeutic pressure in multiple myeloma . To address this issue, we performed large targeted sequencing of bone marrow ...

Multiple Myeloma Insights from Single
Multiple myeloma (MM) is a complex and heterogeneous hematologic malignancy characterized by clonal evolution , genetic instability, and interactions with a supportive tumor microenvironment. These factors contribute to treatment resistance, disease progression, and significant variability in clinical outcomes among patients. This review explores the mechanisms underlying MM progression ...
Abstract In this review, we explore the role of complex interactions between genomic evolution , environmental and genetic predispositions, and immune surveillance in disease progression from precursor conditions smoldering multiple myeloma and monoclonal gammopathy of undetermined significance to multiple myeloma (MM).

A systematic literature review on clonal evolution events preceding ...
Clonal evolution is a continuous process shaped by the tumor microenvironment, inter- clonal competition, and drug-induced selective pressure (Vendramin et al., 2021). Multiple myeloma (MM) is an incurable hematological cancer in which disease initiation and evolution follow a step-wise progression due to increasing genetic instability.






Here, we review recent advances in clonal evolution patterns and genomic landscape dynamics of MM, focusing on their clinical implications. Main models of clonal evolution in multiple myeloma .